Trials / Completed
CompletedNCT02692326
Impact of Cyclic Prolonged Parenteral Nutrition in Neonates
DECREASE OF CHOLESTASIS USING CYCLED PARENTERAL NUTRITION IN NEWBORNS REQUIRING PROLONGED PARENTERAL NUTRITION
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Hospital General Universitario Gregorio Marañon · Academic / Other
- Sex
- All
- Age
- 10 Days – 50 Days
- Healthy volunteers
- Not accepted
Summary
The aim of our study is to compare the incidence of PNAC in newborns receiving cyclic versus continuous parenteral nutrition (PN) in those newborns who need prolonged PN. The secondary aims are to compare incidence of sepsis and catheter related sepsis, mean length of hospital stay, mortality, nutritional status at two years of chronological age and predisposing factors to the development of parenteral nutrition associated cholestasis (PNAC) between the two groups, and to evaluate the adverse effects of the method of cycling used. This was a single-center, prospective randomized not blinded study was conducted in a level 3 neonatal intensive care unit from July 2010 to January 2015. Infants with hemodynamic instability until a stable situation, congenital hepatic disease, preterm infants with diagnosis of respiratory distress syndrome or persistent ductus arteriosus and lack of authorization from the parents or guardians were excluded.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Cyclic parenteral nutrition | Cyclic parenteral nutrition was provided according to a method described by Longhurst et al. Patients were initially cycled of PN for 1 hour per day with increased rate of 1 hour with a maximum time out of PN of 4 hours for preterm babies \< 37 weeks GA and 6 hours for term newborns. Glucose was monitored at half the time without PN to detect the hypoglycemia. |
Timeline
- Start date
- 2010-08-01
- Primary completion
- 2015-01-01
- Completion
- 2015-03-01
- First posted
- 2016-02-26
- Last updated
- 2016-02-26
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT02692326. Inclusion in this directory is not an endorsement.